The role of SALL1-MGST1 axis-mediated ferroptosis inhibition in chemoresistance of retinoblastoma
Zhuang Xiong, Weiwei Zhang, Xuebing Yu, Ruoshu Gu, Xue Zhang · 2026
Read The role of SALL1-MGST1 axis-mediated ferroptosis inhibition in chemoresistance of retinoblastoma by Zhuang Xiong, Weiwei Zhang, Xuebing Yu, Ruoshu Gu, Xue Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353000.txt.
Description
Zhuang Xiong and four colleagues present this 2026 PLOS One laboratory study on why retinoblastoma, the commonest eye cancer of early childhood, resists the drug carboplatin. Their focus is ferroptosis, a form of cell death driven by iron and fat oxidation that cancers can evade. Database analysis flagged a gene regulator called SALL1 as overactive in these tumors, and experiments traced its target.
SALL1 switches on a protective gene, MGST1, which mops up the oxidized fats that would otherwise trigger ferroptosis. Silencing SALL1 made tumor cells stop growing and start dying by ferroptosis, and in a drug-resistant cell line it restored sensitivity to carboplatin. Restoring MGST1 reversed those effects. The authors identify this two-gene axis as a candidate target for overcoming resistance in this childhood cancer.
Catalog record
| CREATOR | Zhuang Xiong, Weiwei Zhang, Xuebing Yu, Ruoshu Gu, Xue Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49335 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |